Get started
Author

Kerstin Brinkert

Observed names: Brinkert, Kerstin, K. Brinkert
OpenAlex ID: A5099525136
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections
2018 · Mania Ackermann, Henning Kempf, et al. · Nature Communications · 165
PDF
Rescue from Pseudomonas aeruginosa Airway Infection via Stem Cell Transplantation
2020 · Kerstin Brinkert, Silke Hedtfeld, et al. · Molecular Therapy · 13
Navigating the Post‐ BCMA / GPRC5D Landscape: Efficacy of Selinexor, Bortezomib, and Dexamethasone After Sequential Immunotherapy Failure in Penta‐Refractory Multiple Myeloma—A Multicenter Analysis
2026 · Maximilian Al‐Bazaz, Winfried Alsdorf, et al. · American Journal of Hematology · 2
Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive review
2024 · Jacqueline Schütt, Kerstin Brinkert, et al. · Cancer Drug Resistance · 2
The role of the bone marrow microenvironment in disease progression and drug resistance in multiple myeloma in the era of novel agents
2025 · Ludovica Guadagno, Jacqueline Schütt, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Selinexor, Bortezomib and Dexamethasone After Sequential BCMA- and GPRC5D-Directed Therapy Failure in Penta-Refractory Multiple Myeloma: A Multicenter Real-World Analysis
2025 · Maximilian Al-Bazaz, Winfried Alsdorf, et al. · Research Square
PDF
Effectiveness of venetoclax based therapy in t(11;14) multiple myeloma with extensive extramedullary disease: a case report
2025 · Kerstin Brinkert, Bernd Heinrich, et al. · Annals of Hematology
PDF
P036 Analysis of the dysfunction of cystic fibrosis macrophages
2021 · C. Rodriguez Gonzalez, D. Tschritter, et al. · Journal of Cystic Fibrosis
PDF
Works count: 9
Citation count: 183
H-index: 2
I10-index: 2
Year
Topic
Type